GlassScriptPhysician profile
Diane B Young
NPI 1063454403
$6,912.41
in general payments reported to CMS, 2019-2025
30 companies · $1,948 in 2025
The $1,948 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.87 · 2023: $945 · 2024: $3,954 · 2025: $1,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,004 · Travel and Lodging: $1,457 · Education: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,004.03 |
| Travel and Lodging | $1,456.93 |
| Education | $386.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,224.44 | 2023-2024 | Axonics |
| Janssen Biotech, INC. | $836.83 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $671.39 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $644.30 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $337.06 | 2023-2025 | Pylarify |
| Pfizer INC. | $307.36 | 2023-2025 | |
| Astellas Pharma US INC | $274.40 | 2023-2025 | Xtandi |
| Novartis Pharmaceuticals Corporation | $213.50 | 2023-2025 | |
| Immunitybio, INC. | $203.72 | 2025 | |
| Abbvie INC. | $170.08 | 2021-2025 | |
| Tolmar, INC. | $141.14 | 2023-2025 | Jatenzo, Eligard |
| Teleflex LLC | $123.13 | 2023-2024 | Urolift, Solesta |
| Tempus Ai, INC | $117.12 | 2024 | Xt Cdx |
| Dendreon Pharmaceuticals LLC | $111.91 | 2023-2025 | Provenge |
| 180 Medical, INC. | $89.40 | 2023-2025 | Gentlecath, Speedicath |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $82.64 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $52.71 | 2023-2024 | Lynparza |
| Merck Sharp & Dohme LLC | $49.14 | 2023-2025 | Keytruda, Lynparza |
| Caris Mpi, INC. | $33.12 | 2025 | Mi Cancer Seek |
| Olympus America INC. | $28.10 | 2023 | Itind System |
| Urogen Pharma, INC. | $26.03 | 2025 | |
| Bioprotect Medical, INC. | $25.48 | 2025 | Bioprotect Balloon Implant System |
| Ferring Pharmaceuticals INC. | $24.34 | 2024 | Adstiladrin |
| Abc Home Medical Supply, INC. | $22.90 | 2025 | |
| Philips North America LLC | $21.23 | 2025 | Disease Management Solutions Equipment Undivided |
| E.R. Squibb & Sons, L.L.C. | $21.13 | 2024 | Sotyktu |
| Telix Pharmaceuticals | $17.26 | 2024 | Illuccix |
| Myriad Genetic Laboratories, INC. | $17.10 | 2024 | Prolaris |
| Vertex Pharmaceuticals Incorporated | $14.71 | 2025 | |
| Boston Scientific Corporation | $10.74 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.